Alessandro Noseda
Directeur/Membre du Conseil chez REGENERX BIOPHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2024
Postes actifs de Alessandro Noseda
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/04/2019 | - |
| Independent Dir/Board Member | 01/04/2019 | - | |
Leadiant Biosciences SpA
 Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Directeur Technique/Scientifique/R&D | 01/01/2014 | - |
| Directeur Général | 01/01/2007 | 01/01/2017 | |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Directeur Technique/Scientifique/R&D | 01/09/2018 | - |
| Corporate Officer/Principal | 01/01/1998 | 01/09/2018 | |
| Thule Therapeutics SA | Directeur/Membre du Conseil | - | - |
| Rostaquo | Directeur/Membre du Conseil | - | - |
| Metheresis Translational Research SA | Directeur/Membre du Conseil | - | - |
Historique de carrière de Alessandro Noseda
Anciens postes connus de Alessandro Noseda
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Leadiant Biosciences SA
 Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Directeur Général | 01/01/2007 | 01/01/2017 |
Formation de Alessandro Noseda
| Wake Forest School of Medicine | Doctorate Degree |
| University of Milan | Doctorate Degree |
Statistiques
Internationale
| Suisse | 5 |
| Etats-Unis | 4 |
| Italie | 3 |
Opérationnelle
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
| Metheresis Translational Research SA | |
Leadiant Biosciences SA
Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Commercial Services |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Health Technology |
| Thule Therapeutics SA | |
| Rostaquo |
- Bourse
- Insiders
- Alessandro Noseda
- Expérience
